Is HBR or JNJ a better dividend investment in 2026?

HBR currently yields 16.79% with a 5% 5-year dividend growth rate. JNJ yields 3.36% with 5.8% growth. The better choice depends on your goal: HBR offers higher current income.

What is the dividend yield difference between HBR and JNJ?

HBR has a forward dividend yield of 16.79% ($2.00/share annually). JNJ yields 3.36% ($4.96/share annually). The yield gap is 13.43 percentage points.

Home › Compare › HBR vs JNJ

HBR vs JNJ: Dividend Comparison 2026

HBR yields 16.79% · JNJ yields 3.36%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 HBR wins by $39.8K in total portfolio value

INVESTMENT

TIME HORIZON10 years

HBR

● Live price

16.79%

Share price

$11.91

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$59.9K

Annual income

$4,708.05

Full HBR calculator →

JNJ

Johnson & Johnson

● Live price

3.36%

Share price

$147.50

Annual div

$4.96

5Y div CAGR

5.8%

Payout ratio

55%

After 10 yrs · $10,000 · DRIP

Portfolio value

$20.0K

Annual income

$827.78

Full JNJ calculator →

Portfolio growth — HBR vs JNJ

📍 HBR pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	HBR	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, HBR + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

HBR pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HBR

Annual income on $10K today (after 15% tax)

$1,427.37/yr

After 10yr DRIP, annual income (after tax)

$4,001.84/yr

JNJ

Annual income on $10K today (after 15% tax)

$285.83/yr

After 10yr DRIP, annual income (after tax)

$703.61/yr

At 15% tax rate, HBR beats the other by $3,298.23/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HBR + JNJ for your $10,000?

HBR: 50%JNJ: 50%

100% JNJ50/50100% HBR

Portfolio after 10yr

$39.9K

Annual income

$2,767.91/yr

Blended yield

6.93%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

HBR

No analyst data

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

+55.1% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HBR buys

JNJ buys

No recent congressional trades found for HBR or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricHBRJNJ

Forward yield	16.79% ✓	3.36%
Annual dividend / share	$2.00	$4.96 ✓
Payout ratio	50% ✓	55%
1-year div growth	0%	4.2% ✓
5-year div CAGR	0%	5.8% ✓
Portfolio after 10y	$59.9K ✓	$20.0K
Annual income after 10y	$4,708.05 ✓	$827.78
Total dividends collected	$30.9K ✓	$5.6K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: HBR vs JNJ ($10,000, DRIP)

Year	HBR Portfolio	HBR Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$12,379	$1,679.26	$10,676	$355.77	+$1.7K → HBR
2	$15,189	$1,942.80	$11,407	$389.39	+$3.8K → HBR
3	$18,480	$2,227.76	$12,198	$426.53	+$6.3K → HBR
4	$22,306	$2,533.14	$13,056	$467.62	+$9.3K → HBR
5	$26,725	$2,857.66	$13,987	$513.12	+$12.7K → HBR
6	$31,796	$3,199.80	$14,998	$563.56	+$16.8K → HBR
7	$37,580	$3,557.85	$16,098	$619.52	+$21.5K → HBR
8	$44,140	$3,929.92	$17,295	$681.69	+$26.8K → HBR
9	$51,544	$4,314.00	$18,599	$750.82	+$32.9K → HBR
10	$59,860	$4,708.05	$20,022	$827.78	+$39.8K → HBR

HBR vs JNJ: Complete Analysis 2026

HBR — Stock

The Trust’s investment objective is to seek to provide exposure to the value of the HBAR, the native asset of the Hedera Network ("HBAR"), held by the Trust, less the expenses of the Trust’s operations and other liabilities. In seeking to achieve its investment objective, the Trust will hold HBAR.

Full HBR Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →

📬

Get this HBR vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HBR vs SCHD HBR vs JEPI HBR vs O HBR vs KO HBR vs MAIN HBR vs ABBV HBR vs MRK HBR vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.